InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Celebi John, Chairman & CEO. Officer active across 1 company, notably Sensei Biotherapeutics, Inc.. In total, 7 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €395. History available since 15 February 2022. The latest transaction was filed on 19 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Celebi John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
5,558 shares@ US$0.4767.1% of flowCommon StockSEC:0001415889-25-005728:0
5,891 shares@ US$0.7912.1% of flowCommon StockSEC:0001415889-24-004235:0
500 shares@ US$0.851.1% of flowCommon StockSEC:0001209191-23-049192:0
Canonical exit: 10 Dec 2023 (T+90)
20,492 shares@ US$1.5079.8% of flowCommon StockSEC:0001209191-23-048966:0
51,893 shares0Common StockSEC:0001209191-23-021541:0
51,893 shares0Common StockSEC:0001209191-23-010731:0
53,900 shares0Common StockSEC:0001209191-22-010976:0
7 of 7 declarations
About Celebi John
John Celebi is the President and CEO of Sensei Biotherapeutics, Inc. He leads the company with a focus on innovation in the field of biotherapies. His strategic leadership aims to develop advanced treatments to improve patient health.
